http://ift.tt/2gRQvT4
Submitted December 16, 2016 at 02:37PM by EightRoundsRapid http://ift.tt/2hr1SSY
Friday, 16 December 2016
Drug maker Actavis UK broke competition law by raising prices of hydrocortisone tablets by more than 12000 percent, Britain's competition watchdog said in a provisional ruling on Friday. Higher prices meant the tablets cost Britain's NHS about £70 million last year, up from about £522,000 previously
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment